open access

Vol 10, No 1 (2014)
Review paper
Published online: 2014-03-06
Get Citation

Radiotherapy in the treatment of Hodgkin’s lymphoma

Marcin Kurowicki, Renata Zaucha
Onkol. Prak. Klin 2014;10(1):16-23.

open access

Vol 10, No 1 (2014)
REVIEW ARTICLES
Published online: 2014-03-06

Abstract

Hodgkin’s lymphoma (HL) is a very radiosensitive and chemosensitive neoplasm. Approximately 90% of patients with early-stage HL can be cured with standard chemotherapy, radiation or combined modalities. Excellent treatment outcomes resulted in searching for equally effective but less toxic therapies. Speaking about radiotherapy it meant changing the irradiated tissue volumes and/or decreasing the total dose. Here we discuss current indications for radiotherapy and principles of treatment planning.

Abstract

Hodgkin’s lymphoma (HL) is a very radiosensitive and chemosensitive neoplasm. Approximately 90% of patients with early-stage HL can be cured with standard chemotherapy, radiation or combined modalities. Excellent treatment outcomes resulted in searching for equally effective but less toxic therapies. Speaking about radiotherapy it meant changing the irradiated tissue volumes and/or decreasing the total dose. Here we discuss current indications for radiotherapy and principles of treatment planning.

Get Citation

Keywords

Hodgkin’s lymphoma, radiotherapy, combined treatment, standards, guidelines, PET

About this article
Title

Radiotherapy in the treatment of Hodgkin’s lymphoma

Journal

Oncology in Clinical Practice

Issue

Vol 10, No 1 (2014)

Article type

Review paper

Pages

16-23

Published online

2014-03-06

Bibliographic record

Onkol. Prak. Klin 2014;10(1):16-23.

Keywords

Hodgkin’s lymphoma
radiotherapy
combined treatment
standards
guidelines
PET

Authors

Marcin Kurowicki
Renata Zaucha

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl